One document found

Our goal is to develop cell and gene therapies for outer retinal layer diseases. First, we performed an autologous iPS cell sheet transplantation of the retinal pigment epithelium (RPE) to demonstrate the safe use of iPS cells from 2013. The cell sheet still works. In a 2017 allogeneic transplant clinical…